Literature DB >> 24750303

Role of obesity on the thickness of primary cutaneous melanoma.

F Skowron1, F Bérard, B Balme, D Maucort-Boulch.   

Abstract

BACKGROUND: Thick primary cutaneous melanoma (PCM) is associated with older age, male sex, being single, a low educational level, self-detection and general practice detection, nodular melanoma (NM) and acral lentiginous melanoma (ALM) types; and are found in the head-neck and lower limb locations. Obesity plays a direct role on melanoma tumour growth, as it has been shown in animal models, but its role in the thickness of PCM remains unknown.
OBJECTIVES: We investigated the impact of obesity on the thickness of invasive PCM.
METHODS: A cross-sectional study was performed in a prospective cohort for which we collected several clinical and histological data already known to be associated with thick PCM and the Body Mass Index from new cases of invasive PCM which were referred to the dermatology department in Valence.
RESULTS: Four hundred and twenty-seven patients were studied. In an univariate analysis, thick PCM was associated with low educational level, obesity, identification by the patient or the general practitioner (GP), location on the cephalic extremity, in a non-visible area of the body, the NM and ALM type, and an ulceration. In a multivariate analysis, NM, ulceration, topography of the melanoma and identification of the melanoma by the patient or GP were significantly associated with thick melanoma. When including only clinical features in the model, low educational level, mode of melanoma identification and obesity were significantly associated with a risk of thick melanoma.
CONCLUSIONS: Obesity is a clinical independent risk factor of thick PCM. For health policies, governments should pay greater attention to detect melanoma in obese patients. Our results encourage the basic research on tumoural growth mechanisms due to obesity in melanoma.
© 2014 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2014        PMID: 24750303     DOI: 10.1111/jdv.12515

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  16 in total

Review 1.  Modifiable Host Factors in Melanoma: Emerging Evidence for Obesity, Diet, Exercise, and the Microbiome.

Authors:  Allison Betof Warner; Jennifer L McQuade
Journal:  Curr Oncol Rep       Date:  2019-07-01       Impact factor: 5.075

2.  The Impact of Obesity on Surgically Treated Locoregional Melanoma.

Authors:  Constance S Harrell Shreckengost; Marvi Tariq; Clara R Farley; Chao Zhang; Keith A Delman; Ragini R Kudchadkar; Michael C Lowe
Journal:  Ann Surg Oncol       Date:  2021-03-14       Impact factor: 5.344

3.  Exosomes as a novel pathway for regulating development and diseases of the skin.

Authors:  Ying Liu; Haidong Wang; Juan Wang
Journal:  Biomed Rep       Date:  2018-01-31

4.  Adipocyte extracellular vesicles carry enzymes and fatty acids that stimulate mitochondrial metabolism and remodeling in tumor cells.

Authors:  Emily Clement; Ikrame Lazar; Camille Attané; Lorry Carrié; Stéphanie Dauvillier; Manuelle Ducoux-Petit; David Esteve; Thomas Menneteau; Mohamed Moutahir; Sophie Le Gonidec; Stéphane Dalle; Philippe Valet; Odile Burlet-Schiltz; Catherine Muller; Laurence Nieto
Journal:  EMBO J       Date:  2020-01-10       Impact factor: 11.598

5.  Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis.

Authors:  Jennifer L McQuade; Carrie R Daniel; Kenneth R Hess; Carmen Mak; Daniel Y Wang; Rajat R Rai; John J Park; Lauren E Haydu; Christine Spencer; Matthew Wongchenko; Stephen Lane; Dung-Yang Lee; Mathilde Kaper; Meredith McKean; Kathryn E Beckermann; Samuel M Rubinstein; Isabelle Rooney; Luna Musib; Nageshwar Budha; Jessie Hsu; Theodore S Nowicki; Alexandre Avila; Tomas Haas; Maneka Puligandla; Sandra Lee; Shenying Fang; Jennifer A Wargo; Jeffrey E Gershenwald; Jeffrey E Lee; Patrick Hwu; Paul B Chapman; Jeffrey A Sosman; Dirk Schadendorf; Jean-Jacques Grob; Keith T Flaherty; Dana Walker; Yibing Yan; Edward McKenna; Jeffrey J Legos; Matteo S Carlino; Antoni Ribas; John M Kirkwood; Georgina V Long; Douglas B Johnson; Alexander M Menzies; Michael A Davies
Journal:  Lancet Oncol       Date:  2018-02-12       Impact factor: 41.316

Review 6.  Body Mass Index and Melanoma Prognosis.

Authors:  Nicoletta Cassano; Stefano Caccavale; Gino A Vena; Giuseppe Argenziano
Journal:  Dermatol Pract Concept       Date:  2021-09-01

Review 7.  Daily Lifestyle and Cutaneous Malignancies.

Authors:  Yu Sawada; Motonobu Nakamura
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

8.  Epidemiological and histopathological aspects of primary cutaneous melanoma in residents of Joinville, 2003-2014.

Authors:  Raquel Bissacotti Steglich; Karina Munhoz de Paula Alves Coelho; Silvana Cardoso; Maria Helena da Costa Naumann Gaertner; Tania Ferreira Cestari; Selma Cristina Franco
Journal:  An Bras Dermatol       Date:  2018 Jan-Feb       Impact factor: 1.896

Review 9.  Obesity and the Impact on Cutaneous Melanoma: Friend or Foe?

Authors:  Lorey K Smith; Shaghayegh Arabi; Emily J Lelliott; Grant A McArthur; Karen E Sheppard
Journal:  Cancers (Basel)       Date:  2020-06-15       Impact factor: 6.639

10.  Body mass index may predict the response to ipilimumab in metastatic melanoma: An observational multi-centre study.

Authors:  Georg Richtig; Christoph Hoeller; Martin Wolf; Ingrid Wolf; Barbara M Rainer; Günter Schulter; Markus Richtig; Martin R Grübler; Anna Gappmayer; Thomas Haidn; Julian Kofler; Rainer Huegel; Bernhard Lange-Asschenfeldt; Martin Pichler; Stefan Pilz; Akos Heinemann; Erika Richtig
Journal:  PLoS One       Date:  2018-10-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.